Valeant picks up AstraZeneca psoriasis drug after Amgen exit
Valeant said that it would make an upfront payment of $100 million to AstraZeneca
Canada's Valeant Pharmaceuticals International…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Latest Updates » Page 366
Browsing Category
Latest Updates
Cipla appoints Umang Vohra and Prabir Jha to its management team
Vohra will be the global chief financial and strategy officer and Jha will take over as global chief people officer
Cipla has…
Novartis in global partnership with Amgen
To develop and commercialise pioneering neuroscience treatments
Novartis has entered into a global collaboration with Amgen to…
Biocon Academy opens enrollment for biosciences programme
The admission process for Batch 6 will be on till October 31, 2015 and classes will commence on January 11, 2016
Biocon Academy,…
Natco Pharma plans five new products for US market
The Rs 850-crore company expects to see organic growth of 15-20 per cent
Natco Pharma is preparing to launch about four to five…
Dr Harsh Vardhan launches web-enabled project management information system for DBT projects
A mobile app was also unveiled
Dr Harsh Vardhan, Union Minister for Science & Technology & Earth Sciences, recently…
Sun Pharma completes GSK’s opiates biz acquisition in Australia
Significantly expands NRM capability through two opiates manufacturing facilities in Australia
Sun Pharmaceutical Industries has…
‘DRILS Synergy 2015’ symposium organised
The programme saw industry leaders and academia under one roof to discuss opportunities to build a culture of innovation and…
Strides completes acquisition of Aspen’s generic biz in Australia
The acquired business will be integrated and consolidated with Strides effective September 1, 2015
Strides Arcolab has completed…
32,000 delegates to attend CPhI and P-MEC India
The events from Dec 1 to 3, 2015 will co-locate with ICSE and BioPh
CPhI and P-MEC India will be held at the Bombay Convention…